Read + Share
Daniel A, Ghez D, Ravaiau C, Cavalieri D, et al. Ibrutinib as a treatment of hematologic autoimmune disorders in patients with
indolent B-cell lymphoma. Eur J Haematol 2022 Sep 1. doi: 10.1111/ejh.13858.
PMID: 36048142
|
 |
|
Daniel A, Ghez D, Ravaiau C, Cavalieri D, et al. Ibrutinib as a treatment of hematologic autoimmune disorders in patients with
indolent B-cell lymphoma. Eur J Haematol 2022 Sep 1. doi: 10.1111/ejh.13858.
PMID: 36048142
|
|
|
|